These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical study on effect of tongluo capsule in treating diabetic nephropathy caused chronic renal failure].
    Author: Sun WS, Wu XL, Qiao CL.
    Journal: Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Aug; 24(8):704-6. PubMed ID: 15366593.
    Abstract:
    OBJECTIVE: To observe the therapeutic effect of Tongluo capsule (TLC) in treating diabetic nephropathy (DN) complicated chronic renal failure (CRF), and to explore its mechanism preliminarily. METHODS: Ninety-seven patients with DN-CRF were randomly divided into the TCM group (n = 50) and the WM group (n = 47) to observe the changes of urinary protein per 24 hrs (UP/24h), renal function, creatinine (Cr), blood urea nitrogen (BUN), blood lipids (TG, TC, HDL-C, LDL-C) and serum transforming growth factor-beta1 (TGF-beta1) before and after treatment. RESULTS: After 6 months of treatment, levels of UP/24h, Cr, BUN and TGF-beta1 significantly lowered in both groups (P<0.01), and a better effect was showed in the TCM group in aspects of lowering Cr, BUN and TGF-beta1 (P<0.01). Besides, TLC also showed effect in lowering the serum lipid parameters (P<0.05 or P<0.01). CONCLUSION: Effect of TLC in treating DN-CRF might be through lowering the levels of blood lipids and serum TGF-beta1.
    [Abstract] [Full Text] [Related] [New Search]